Berlin, Germany

Michael Strauss, Deceased

This inventor holds 1 USPTO granted patent. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Michael Strauss

Introduction

Michael Strauss was a notable inventor known for his contributions to the field of molecular biology. He was based in Berlin, Germany, and his work has had a lasting impact on genetic research. Strauss is remembered for his innovative approach to ribozyme technology, which has implications for gene therapy and molecular diagnostics.

Latest Patents

One of Michael Strauss's significant patents is the "Ribozyme gene library and method for making." This patent describes a ribozyme library that comprises a collection of ribozyme genes encoding a hammerhead structure. The library includes flanking sequences of random nucleotides cloned at least once into an expression cassette for ribozyme expression. This invention has paved the way for advancements in genetic engineering and therapeutic applications.

Career Highlights

Throughout his career, Strauss was associated with the Max Planck Society for the Advancement of Science, where he conducted groundbreaking research. His work focused on the development of ribozymes, which are RNA molecules capable of catalyzing biochemical reactions. This innovative research has contributed to a deeper understanding of RNA biology and its potential applications in medicine.

Collaborations

Michael Strauss collaborated with several prominent scientists during his career, including Andre Lieber. Their joint efforts in research have led to significant advancements in the field of molecular biology.

Conclusion

Michael Strauss's contributions to the field of molecular biology, particularly through his patent on ribozyme technology, have left a lasting legacy. His innovative work continues to inspire future research in genetic engineering and therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…